Genesystem Co., Ltd. (KOSDAQ:363250)
South Korea
· Delayed Price · Currency is KRW 5,500.00
-340.00 (-5.82%)
At close: Apr 28, 2026
Genesystem Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Operating Revenue | 381.36 | 1,208 | 897.03 | 3,653 |
| Other Revenue | - | 0 | 0 | - |
| Revenue | 381.36 | 1,208 | 897.03 | 3,653 |
| Revenue Growth (YoY) | -68.42% | 34.64% | -75.44% | - |
| Cost of Revenue | 2,846 | 3,028 | 2,483 | 2,486 |
| Gross Profit | -2,465 | -1,820 | -1,586 | 1,167 |
| Selling, General & Admin | 3,658 | 3,885 | 4,119 | 3,855 |
| Research & Development | 2,689 | 3,344 | 3,425 | 3,354 |
| Amortization of Goodwill & Intangibles | 598.69 | 776.44 | 196.51 | 73.49 |
| Other Operating Expenses | 97.64 | 85.56 | 76.6 | 72.81 |
| Operating Expenses | 7,225 | 8,296 | 7,898 | 7,772 |
| Operating Income | -9,690 | -10,116 | -9,484 | -6,605 |
| Interest Expense | -124.58 | -136.25 | -133.61 | -95.47 |
| Interest & Investment Income | 76.06 | 300.54 | 363.75 | 205.31 |
| Earnings From Equity Investments | - | - | 882.76 | - |
| Currency Exchange Gain (Loss) | -5.75 | 70.28 | 76.04 | 234.36 |
| Other Non Operating Income (Expenses) | 8.48 | 7.12 | 124.59 | 29.27 |
| EBT Excluding Unusual Items | -9,736 | -9,874 | -8,171 | -6,231 |
| Gain (Loss) on Sale of Investments | 94.84 | 194.97 | 258.36 | -825.27 |
| Gain (Loss) on Sale of Assets | 5 | -0.18 | - | -3.14 |
| Asset Writedown | -6,275 | - | - | - |
| Pretax Income | -15,911 | -9,679 | -7,913 | -7,060 |
| Income Tax Expense | -1,242 | -150.73 | 146.41 | 1,936 |
| Earnings From Continuing Operations | -14,669 | -9,529 | -8,059 | -8,996 |
| Minority Interest in Earnings | 2,714 | 613.41 | 143.55 | - |
| Net Income | -11,955 | -8,915 | -7,915 | -8,996 |
| Net Income to Common | -11,955 | -8,915 | -7,915 | -8,996 |
| Shares Outstanding (Basic) | 7 | 7 | 7 | 7 |
| Shares Outstanding (Diluted) | 7 | 7 | 7 | 7 |
| Shares Change (YoY) | -0.46% | -1.47% | 0.69% | - |
| EPS (Basic) | -1754.00 | -1302.00 | -1139.05 | -1303.50 |
| EPS (Diluted) | -1754.00 | -1302.00 | -1139.05 | -1303.50 |
| Free Cash Flow | -7,103 | -7,595 | -8,174 | -6,655 |
| Free Cash Flow Per Share | -1042.12 | -1109.26 | -1176.31 | -964.32 |
| Gross Margin | - | -150.69% | -176.81% | 31.96% |
| Operating Margin | -2541.03% | -837.58% | -1057.33% | -180.80% |
| Profit Margin | -3134.97% | -738.17% | -882.41% | -246.26% |
| Free Cash Flow Margin | -1862.60% | -628.89% | -911.27% | -182.18% |
| EBITDA | -8,672 | -8,873 | -8,939 | -6,219 |
| EBITDA Margin | - | - | - | -170.23% |
| D&A For EBITDA | 1,018 | 1,242 | 545.39 | 386.3 |
| EBIT | -9,690 | -10,116 | -9,484 | -6,605 |
| EBIT Margin | - | - | - | -180.80% |
| Advertising Expenses | 248.48 | 182.95 | 281.68 | 239.36 |
Source: S&P Capital IQ. Standard template. Financial Sources.